These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25538273)

  • 61. Clinical Correlates of Human Immunodeficiency Virus-1 (HIV-1) DNA and Inducible HIV-1 RNA Reservoirs in Peripheral Blood in Children With Perinatally Acquired HIV-1 Infection With Sustained Virologic Suppression for at Least 5 Years.
    Bitnun A; Ransy DG; Brophy J; Kakkar F; Hawkes M; Samson L; Annabi B; Pagliuzza A; Morand JA; Sauve L; Chomont N; Lavoie S; Kim J; Sandstrom P; Wender PA; Lee T; Singer J; Read SE; Soudeyns H;
    Clin Infect Dis; 2020 Feb; 70(5):859-866. PubMed ID: 30919879
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intracellular and cell-free (infectious) HIV-1 in rectal mucosa.
    Di Stefano M; Favia A; Monno L; Lopalco P; Caputi O; Scardigno AC; Pastore G; Fiore JR; Angarano G
    J Med Virol; 2001 Dec; 65(4):637-43. PubMed ID: 11745925
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection.
    Schmid A; Gianella S; von Wyl V; Metzner KJ; Scherrer AU; Niederöst B; Althaus CF; Rieder P; Grube C; Joos B; Weber R; Fischer M; Günthard HF
    PLoS One; 2010 Oct; 5(10):e13310. PubMed ID: 20967271
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lack of detection of human immunodeficiency virus type 1 in the saliva of infected children and adolescents.
    Melvin AJ; Tamura GS; House JK; Hobson AC; Cone RW; Frenkel LM; Burchett S
    Arch Pediatr Adolesc Med; 1997 Mar; 151(3):228-32. PubMed ID: 9080928
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cell-associated HIV RNA: a dynamic biomarker of viral persistence.
    Pasternak AO; Lukashov VV; Berkhout B
    Retrovirology; 2013 Apr; 10():41. PubMed ID: 23587031
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Near normalization of peripheral blood markers in HIV-infected patients on long-term suppressive antiretroviral therapy: a case-control study.
    Brochado-Kith O; Martinez I; Berenguer J; Medrano LM; González-García J; Garcia-Broncano P; Jiménez-Sousa MÁ; Carrero A; Hontañón V; Muñoz-Fernández MÁ; Fernández-Rodríguez A; Resino S
    AIDS; 2020 Nov; 34(13):1891-1897. PubMed ID: 32796212
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intracellular Nef detected in peripheral blood mononuclear cells from HIV patients.
    Wang T; Green LA; Gupta SK; Amet T; Byrd DJ; Yu Q; Twigg HL; Clauss M
    AIDS Res Hum Retroviruses; 2015 Feb; 31(2):217-20. PubMed ID: 25062432
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Changes in HIV reservoirs during long-term antiretroviral therapy.
    Hong FF; Mellors JW
    Curr Opin HIV AIDS; 2015 Jan; 10(1):43-8. PubMed ID: 25402706
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Viral Reservoir in Early-Treated Human Immunodeficiency Virus-Infected Children and Markers for Sustained Viral Suppression.
    Ajibola G; Garcia-Broncano P; Maswabi K; Bennett K; Hughes MD; Moyo S; Mohammed T; Jean-Philippe P; Sakoi M; Batlang O; Lockman S; Makhema J; Kuritzkes DR; Lichterfeld M; Shapiro RL
    Clin Infect Dis; 2021 Aug; 73(4):e997-e1003. PubMed ID: 33605999
    [TBL] [Abstract][Full Text] [Related]  

  • 70. HIV DNA levels and decay in a cohort of 111 long-term virally suppressed patients.
    Golob JL; Stern J; Holte S; Kitahata MM; Crane HM; Coombs RW; Goecker E; Woolfrey AE; Harrington RD
    AIDS; 2018 Sep; 32(15):2113-2118. PubMed ID: 30005008
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy.
    Kearney MF; Spindler J; Shao W; Yu S; Anderson EM; O'Shea A; Rehm C; Poethke C; Kovacs N; Mellors JW; Coffin JM; Maldarelli F
    PLoS Pathog; 2014 Mar; 10(3):e1004010. PubMed ID: 24651464
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Impact of Antiretroviral Therapy on HIV-1 Persistence: The Case for Early Initiation.
    Hong FF; Mellors JW
    AIDS Rev; 2015; 17(2):71-82. PubMed ID: 26035165
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapy.
    Fischer M; Joos B; Niederöst B; Kaiser P; Hafner R; von Wyl V; Ackermann M; Weber R; Günthard HF
    Retrovirology; 2008 Nov; 5():107. PubMed ID: 19036147
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sustained Virologic Suppression Reduces HIV-1 DNA Proviral Levels and HIV Antibodies in Perinatally HIV-Infected Children Followed from Birth.
    Fuller T; Kerin T; Cortado R; Benamor Teixeira ML; Fragoso da Silveira Gouvêa MI; Moreira C; Santos Cruz ML; Pilotto JH; Gomes I; Santos B; Rocha T; Soni PR; Joao E; Shin-Sim M; Bryson Y; Nielsen-Saines K
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366448
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Rapid Initiation of Antiretrovirals in Two Newly Diagnosed HIV-infected Infants.
    Clarke DF; Yildirim I; Cooper ER
    Pediatr Infect Dis J; 2017 Jan; 36(1):61-62. PubMed ID: 27749654
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Associations of HIV persistence, cigarette smoking, inflammation, and pulmonary dysfunction in people with HIV on antiretroviral therapy.
    Cyktor J; Qin S; Staines B; Nouraie M; Fitzpatrick M; Kessinger C; DeSensi R; Huang L; Rinaldo CR; Kingsley L; Tien PC; Mellors JW; Morris A
    Medicine (Baltimore); 2022 Jul; 101(27):e29264. PubMed ID: 35801755
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical validation of a quantitative HIV-1 DNA droplet digital PCR assay: Applications for detecting occult HIV-1 infection and monitoring cell-associated HIV-1 dynamics across different subtypes in HIV-1 prevention and cure trials.
    Powell L; Dhummakupt A; Siems L; Singh D; Le Duff Y; Uprety P; Jennings C; Szewczyk J; Chen Y; Nastouli E; Persaud D
    J Clin Virol; 2021 Jun; 139():104822. PubMed ID: 33930698
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trial.
    Payne H; Chan MK; Watters SA; Otwombe K; Hsiao NY; Babiker A; Violari A; Cotton MF; Gibb DM; Klein NJ
    AIDS Res Ther; 2021 Sep; 18(1):63. PubMed ID: 34587974
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Increasing contribution of integrated forms to total HIV DNA in blood during HIV disease progression from primary infection.
    Trémeaux P; Lenfant T; Boufassa F; Essat A; Mélard A; Gousset M; Delelis O; Viard JP; Bary M; Goujard C; Rouzioux C; Meyer L; Avettand-Fenoel V;
    EBioMedicine; 2019 Mar; 41():455-464. PubMed ID: 30803934
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HIV-1 group P infection: towards a dead-end infection?
    Alessandri-Gradt E; De Oliveira F; Leoz M; Lemee V; Robertson DL; Feyertag F; Ngoupo PA; Mauclere P; Simon F; Plantier JC
    AIDS; 2018 Jun; 32(10):1317-1322. PubMed ID: 29547436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.